Clinical trial

Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD

NCT03526536

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-05-01

PhasePHASE4

Study timeline

Study start (actual)2018-05-01Date precision: day

Registry last updated2020-10-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

End-Stage Renal Diseaseunresolved

Diabetes Mellitusunresolved

Interventions

IV Novolin R human insulinDRUG

Sponsors & collaborators

State University of New York - Downstate Medical Centerlead sponsor

Mapped research locations

BrooklynNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03526536 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.